The combination of an investigational cell therapy using tumor-infiltrating lymphocytes and pembrolizumab induced responses among a small cohort of patients with metastatic head and neck squamous cell carcinoma, study results showed.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045